openPR Logo
Press release

Ocular Drug Delivery Global Market Leading Global Companies and Regional Average Pricing Analysis By 2027 | Pfizer Inc., Roche Holding AG, AbbVie Inc., Novartis AG, Allergan Inc.

09-21-2023 06:09 AM CET | Health & Medicine

Press release from: The Business research company

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Ocular Drug Delivery Global Market Report 2023 identifies an increase in the prevalence of eye disorders is expected to propel the growth of the ocular drug delivery market going forward. Eye disorders refer to a wide range of conditions that affect the eyes, vision, or the structures surrounding the eyes.

The global ocular drug delivery market size is expected to grow from $16.27 billion in 2022 to $17.39 billion in 2023 at a compound annual growth rate (CAGR) of 6.86%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of ocular drug delivery market is expected to reach $22.99 billion in 2027 at a CAGR of 7.23%.

Download Free Sample of Ocular Drug Delivery Market Report
https://www.thebusinessresearchcompany.com/sample.aspx?id=11901&type=smp

Major players in the ocular drug delivery market are Pfizer Inc., Roche Holding AG, AbbVie Inc., Novartis AG, Allergan Inc., Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Genentech Inc., Santen Pharmaceutical Co. Ltd., Akorn Inc., Valeant Pharmaceuticals International Inc., Aerie Pharmaceuticals Inc., Alimera Sciences Inc., Ocular Therapeutix Inc., Ophthotech Corporation, Acucela Inc., Graybug Vision Inc., Amakem NV, Kala Pharmaceuticals Inc., Icon Bioscience Inc., Clearside Biomedical Inc., Aerpio Therapeutics Inc., Senju Pharmaceutical Co. Ltd., Shire plc, Spark Therapeutics Inc., Sucampo Pharmaceuticals Inc., Carl Zeiss Meditec AG, and EyeGate Pharmaceuticals Inc.

Product innovation is a key trend gaining popularity in the ocular drug delivery market. Companies operating in the ocular drug delivery market are focused on developing new product innovations to sustain their position in the market.

Read More On The Global Ocular Drug Delivery Market Report Here:
https://www.thebusinessresearchcompany.com/report/ocular-drug-delivery-global-market-report

The Ocular Drug Delivery Market Is Segmented -
• By Technology: Implantable Ocular Drug Delivery Systems, Particulate Drug Delivery Systems, Nano-Particle Drug Delivery System, Other Technologies
• By Formulation: Liposomes And Nanoparticles, Solution, Emulsion, Suspension, Ointment
• By Disease: Glaucoma, Diabetic Retinopathy, Dry Eye Syndrome, Macular Degeneration, Cataract, Diabetic Macular Edema, Other Diseases
• By End User: Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Ocular Drug Delivery market.

The Business Research Company's "Global Ocular Drug Delivery Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Ocular Drug Delivery Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11901

The Table Of Content For The Ocular Drug Delivery Market Include:
1. Executive Summary
2. Ocular Drug Delivery Market Characteristics
3. Ocular Drug Delivery Market Trends And Strategies
4. Ocular Drug Delivery Market - Macro Economic Scenario
5. Ocular Drug Delivery Market Size And Growth
.....
26. Africa Ocular Drug Delivery Market
27. Ocular Drug Delivery Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Ocular Drug Delivery Market
29. Ocular Drug Delivery Market Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ocular Drug Delivery Global Market Leading Global Companies and Regional Average Pricing Analysis By 2027 | Pfizer Inc., Roche Holding AG, AbbVie Inc., Novartis AG, Allergan Inc. here

News-ID: 3215995 • Views:

More Releases from The Business research company

Rising Cancer Prevalence Fuels Growth Of Antiemetics And Antinauseants Market: Strategic Insights Driving Antiemetics And Antinauseants Market Momentum in 2025
Rising Cancer Prevalence Fuels Growth Of Antiemetics And Antinauseants Market: S …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Antiemetics And Antinauseants Market Size By 2025? The market for antiemetics and antinauseants has been progressively increasing in size over the past few years. It is projected to escalate from $8.19 billion in 2024 to approximately $8.48 billion in 2025, exhibiting a compound annual growth
Increasing Cancer Epidemic Driving Growth In The Oligonucleotide Therapy Market: The Driving Engine Behind Oligonucleotide Therapy Market Evolution in 2025
Increasing Cancer Epidemic Driving Growth In The Oligonucleotide Therapy Market: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Oligonucleotide Therapy Market Size Growth Forecast: What to Expect by 2025? The market size for oligonucleotide therapy has been swiftly expanding in the past few years. Projected growth is from $5.61 billion in 2024 to $6.2 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.5%. The
Anesthetics Market Landscape to 2034: Key Forces Shaping the Next Decade of Growth
Anesthetics Market Landscape to 2034: Key Forces Shaping the Next Decade of Grow …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Anesthetics Market Size By 2025? In the past few years, there has been a steady increase in the size of the anesthetics market. It is projected to expand from $9.73 billion in 2024 to $10.16 billion in 2025, with a compound annual growth rate (CAGR)
Future of the Meningococcal Vaccines Market: Trends, Innovations, and Key Forecasts Through 2034
Future of the Meningococcal Vaccines Market: Trends, Innovations, and Key Foreca …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Meningococcal Vaccines Market Size Growth Forecast: What to Expect by 2025? In recent times, the dimension of the meningococcal vaccines market has seen robust expansion. It is projected to swell from $3.89 billion in 2024 to $4.26 billion in 2025, marking a compound annual growth rate (CAGR) of 9.3%.

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase